SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

Our research on cell-based therapies also includes cutting-edge immunotherapies ... The device may help pave the way toward making gene therapy accessible and affordable beyond a handful of ...

Weill Cornell Medicine researchers have discovered a way ovarian tumors cripple immune cells: by tampering with their ability ...

Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...

Cellectis SA (CLLS) has released an update. Cellectis SA is showcasing its innovative strategies to improve the effectiveness of CAR T-cell ...

The global cell and gene therapy market size was valued at USD 30.27 billion in 2024 and is projected to reach USD 190.82 ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of using decades-old transplant drugs alongside cutting-edge CRISPR medicines.

Three investigators at Baylor College of Medicine’s (BCM) Center for Cell and Gene Therapy Institute (CAGT) have been awarded G-Rex Grants totaling $475,000 by ScaleReady, in collaboration with Wilson ...

including updates on ex vivo gene therapy for hemoglobinopathies and advancements in CAR T-cell therapy for paediatric solid tumours. Furthermore, the congress will delve into the challenges in ...

In-depth interviews and an online survey found support for gene therapy as a treatment for inherited blood disorders, but ...

Using the established cancer cell databases GDSC, CTRP and COSMIC, researchers developed a combined score of the 36 genes ...